106 related articles for article (PubMed ID: 7631139)
1. Enhancement of interleukin-6 production by fibrinogen degradation product D in human peripheral monocytes and perfused murine liver.
Mandl J; Csala M; Léránt I; Bánhegyi G; Biró J; Machovich R; Falus A
Scand J Immunol; 1995 Jul; 42(1):175-8. PubMed ID: 7631139
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin-independent stimulation of interleukin-6 production by fibrinogen degradation product D in perfused murine liver.
Csala M; Léránt I; Bánhegyi G; Kardon T; Puskás F; Mucha I; Machovich R; Falus A; Mandl J
Scand J Immunol; 1998 Sep; 48(3):269-71. PubMed ID: 9743211
[TBL] [Abstract][Full Text] [Related]
3. Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-1 beta, IL-6 and plasminogen activator inhibitors from monocytes in vitro.
Robson SC; Shephard EG; Kirsch RE
Br J Haematol; 1994 Feb; 86(2):322-6. PubMed ID: 8199021
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of endotoxin and fibrinogen degradation products (FDPS) on liver synthesis of fibrinogen and albumin: evidence for the involvement of a novel monokine in the stimulation of fibrinogen synthesis induced by FDPS.
Moshage HJ; Princen HM; van Pelt J; Roelofs HM; Nieuwenhuizen W; Yap SH
Int J Biochem; 1990; 22(12):1393-400. PubMed ID: 2276413
[TBL] [Abstract][Full Text] [Related]
5. New enzyme immunoassay of fibrin-fibrinogen degradation products in plasma using a monoclonal antibody.
Koopman J; Haverkate F; Koppert P; Nieuwenhuizen W; Brommer EJ; Van der Werf WG
J Lab Clin Med; 1987 Jan; 109(1):75-84. PubMed ID: 3540164
[TBL] [Abstract][Full Text] [Related]
6. The putative role of fibrin fragments in the biosynthesis of fibrinogen by hepatoma cells.
Wang Y; Fuller GM
Biochem Biophys Res Commun; 1991 Mar; 175(2):562-7. PubMed ID: 2018504
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of fibrinogen synthesis in cultured rat hepatocytes by fibrinogen degradation product fragment D.
LaDuca FM; Tinsley LA; Dang CV; Bell WR
Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8788-92. PubMed ID: 2813424
[TBL] [Abstract][Full Text] [Related]
8. CD11b/CD18 mediates the neutrophil chemotactic activity of fibrin degradation product D domain.
Gross TJ; Leavell KJ; Peterson MW
Thromb Haemost; 1997 May; 77(5):894-900. PubMed ID: 9184399
[TBL] [Abstract][Full Text] [Related]
9. Modulation of polymorphonuclear leukocyte microbicidal activity and oxidative metabolism by fibrinogen degradation products D and E.
Kazura JW; Wenger JD; Salata RA; Budzynski AZ; Goldsmith GH
J Clin Invest; 1989 Jun; 83(6):1916-24. PubMed ID: 2542377
[TBL] [Abstract][Full Text] [Related]
10. Plasma alpha 2-plasmin inhibitor-plasmin complex and FDP-D-Dimer in fulminant hepatic failure.
Tomiya T; Hayashi S; Ogata I; Fujiwara K
Thromb Res; 1989 Feb; 53(3):253-60. PubMed ID: 2524118
[TBL] [Abstract][Full Text] [Related]
11. The effect of homologous thrombin and fibrinogen degradation products on fibrinogen synthesis in rabbits.
Kessler CM; Bell WR
J Lab Clin Med; 1979 May; 93(5):768-82. PubMed ID: 219123
[TBL] [Abstract][Full Text] [Related]
12. Pro-inflammatory effect of fibrinogen and FDP on vascular smooth muscle cells by IL-6, TNF-α and iNOS.
Lu PP; Liu JT; Liu N; Guo F; Ji YY; Pang X
Life Sci; 2011 May; 88(19-20):839-45. PubMed ID: 21439977
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y
Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330
[TBL] [Abstract][Full Text] [Related]
14. Potent activity of peripheral blood lymphocytes in inducing hepatocyte stimulating factor and urokinase in monocytes.
Vasse M; Mirshahi SS; Soria J; Mirshahi M; Borg JY; Monconduit M; Soria C
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):143-7. PubMed ID: 8457643
[TBL] [Abstract][Full Text] [Related]
15. The role of fibrin degradation products in neutrophil recruitment to the lung.
Leavell KJ; Peterson MW; Gross TJ
Am J Respir Cell Mol Biol; 1996 Jan; 14(1):53-60. PubMed ID: 8534486
[TBL] [Abstract][Full Text] [Related]
16. Biological behavior of higher molecular weight products of fibrinolysis.
Chang ML; Bang NU
J Lab Clin Med; 1977 Jul; 90(1):216-26. PubMed ID: 874368
[TBL] [Abstract][Full Text] [Related]
17. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism].
Yamasawa F; Hasegawa N; Asano K; Sayama K; Fujita H; Urano T; Aoki T; Ishizaka A; Kanazawa M; Kawashiro T
Kokyu To Junkan; 1992 Jul; 40(7):685-90. PubMed ID: 1387724
[TBL] [Abstract][Full Text] [Related]
18. [Studies on the blood coagulation factor XIII in patients with increased levels of FDP D-dimer].
Okumura N; Matsuzawa A; Terasawa F; Kameko M; Sasaki Y; Nakagoshi R; Ishikawa S; Hashikura Y; Matsunami H; Kawasaki S
Rinsho Byori; 1995 Mar; 43(3):269-74. PubMed ID: 7745833
[TBL] [Abstract][Full Text] [Related]
19. Role of D dimer in patients with elevated fibrinogen degradation products in serum: further study in chronic myelogenous leukemia.
Saito M; Asakura H; Jokaji H; Uotanzi C; Kumabashiri I; Yoshida T; Hashizume K; Matsuda T
Acta Haematol; 1990; 84(3):149-55. PubMed ID: 2123066
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of disseminated intravascular coagulation. Role of D-dimer.
Carr JM; McKinney M; McDonagh J
Am J Clin Pathol; 1989 Mar; 91(3):280-7. PubMed ID: 2646905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
